High-dose pilot studies in extensive-stage small-cell lung cancer

Small-cell lung cancer is rarely cured with standard chemotherapy, despite initial good responses. The concept of high-dose induction therapy for extensive-stage patients has been explained in a series of pilot studies. The rationale of this approach and the most recent preliminary results will be p...

Full description

Saved in:

Bibliographic Details
Published in:	Seminars in oncology Vol. 13; no. 3 Suppl 3; p. 37
Main Authors:	Johnson, D H, Hande, K R, Porter, L L, Hainsworth, J D, Wolff, S N, Greco, F A
Format:	Journal Article
Language:	English
Published:	United States 01-09-1986
Subjects:	Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Small Cell - drug therapy Cisplatin - administration & dosage Cyclophosphamide - administration & dosage Etoposide - administration & dosage Humans Lung Neoplasms - drug therapy Pilot Projects Remission Induction
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Small-cell lung cancer is rarely cured with standard chemotherapy, despite initial good responses. The concept of high-dose induction therapy for extensive-stage patients has been explained in a series of pilot studies. The rationale of this approach and the most recent preliminary results will be presented.
ISSN:	0093-7754